"TAP não sobrevive se se mantiver pública", garante Pinto Luz

[atomez]

Este é um sector ainda pouco consolidado, a maior farmacêutica mundial só tem à volta de 10% do mercado.

Three more mega-mergers could happen in 2009

More mega-mergers are a possibility in 2009, according to a new report that speculates that three more deals could happen this year, with Bristol-Myers Squibb and Bayer the most likely targets.

The Urch Publishing report anticipates movement in the list of top 10 pharmaceutical companies and believes that Sanofi-Aventis and Novartis are best placed to make big deals.

Sanofi appears to have ruled itself out of this round of mega-mergers but the report claims that the three deals this year have shifted the landscape and may encourage others to buy big.

GlaxoSmithKline has also said it is looking at smaller deals but the report claims that it, as well as Eli Lilly and Takeda, is under pressure to think big to satisfy investors and compete with the newly merged companies.